Socioeconomic Disadvantage Lowers Prostate Cancer Screening Rates: Study Reveals Inequities

What is it about?

The study examines the influence of the Area Deprivation Index (ADI) on prostate-specific antigen (PSA) screening patterns in a North American cohort. Utilizing data from Henry Ford Health System, the study assessed men aged 50-69 years without prior prostate cancer diagnoses to observe socioeconomic impacts on screening. Results indicated that men in the most socioeconomically deprived areas (highest ADI quartile) had lower PSA screening rates and were predominantly non-Hispanic Black with higher comorbidities. Poisson regression analysis revealed significant disparities in screening likelihood among different ADI quartiles. These findings underscore the need for targeted healthcare strategies to address socioeconomic barriers and improve preventive care access, particularly in deprived neighborhoods.

Featured Image

Why is it important?

This research is important because it investigates the relationship between socioeconomic factors, measured by the Area Deprivation Index (ADI), and prostate-specific antigen (PSA) screening patterns. Understanding this relationship is crucial as it sheds light on how neighborhood socioeconomic disadvantage impacts access to preventive healthcare, particularly for prostate cancer screening. This study is the first to examine the impact of ADI on prostate cancer screening practices, addressing a significant gap in the literature. The findings have important implications for healthcare policy and practice, especially in addressing disparities in cancer screening and outcomes among different socioeconomic groups. Key Takeaways: 1. Socioeconomic Disparity: The study reveals that men living in more deprived areas (higher ADI scores) have lower rates of PSA screening frequency, highlighting how socioeconomic factors can limit access to preventive healthcare. 2. Racial Disparities: Non-Hispanic Black men were more likely to live in areas with higher deprivation (Q4 ADI), had higher comorbidity rates, and a lower probability of receiving multiple PSA tests, underscoring the intersection of race and socioeconomic factors in healthcare access. 3. Need for Targeted Interventions: The findings emphasize the necessity for more inclusive and targeted outreach strategies to improve access to prostate cancer screening in socioeconomically disadvantaged areas, potentially reducing disparities in prostate cancer outcomes.